0001209191-23-054837.txt : 20231109 0001209191-23-054837.hdr.sgml : 20231109 20231109162513 ACCESSION NUMBER: 0001209191-23-054837 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231108 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirk Christopher J. CENTRAL INDEX KEY: 0001744253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 231392952 MAIL ADDRESS: STREET 1: C/O KEZAR LIFE SCIENCES, INC. STREET 2: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kezar Life Sciences, Inc. CENTRAL INDEX KEY: 0001645666 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473366145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-822-5600 MAIL ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-08 0 0001645666 Kezar Life Sciences, Inc. KZR 0001744253 Kirk Christopher J. C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 CEO 0 Employee Stock Option (right to buy) 0.84 2023-11-08 4 A 0 875000 0.00 A 2033-11-07 Common Stock 875000 875000 D One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on December 7, 2023, subject to the Reporting Person continuing to provide service through each such date. /s/ Marc Belsky, Attorney-in-Fact 2023-11-09